PMID- 7824160 OWN - NLM STAT- MEDLINE DCOM- 19950210 LR - 20190701 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 177 IP - 1-2 DP - 1994 Aug 15 TI - Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. PG - 111-5 AB - The effect of the R(-) and S(+) isomers of 3,4-methylenedioxyamphetamine (MDA) and its N-methyl analog 3,4-methylenedioxymethamphetamine (MDMA) on [3H]inositol monophosphate accumulation was studied in cells expressing either 5-HT2A or 5-HT2C receptors. The isomers of MDA produced a concentration dependent increase in phosphatidyl inositol (PI) hydrolysis at the 5-HT2A receptors, with the R(-) isomer of MDA being more potent than the S(+) at the 5-HT2A receptor. The R(-) and S(+) isomers of MDMA were significantly less efficacious at the 5-HT2A receptor as compared to MDA; S(+)MDMA had no effect. At the 5-HT2C receptor, both R(-) and S(+)MDA were equipotent at stimulating PI hydrolysis, with the S(+) isomer of MDMA being more efficacious at the 5-HT2C receptor compared with the R(-) isomer. In all cases at both the 5-HT2A and 5-HT2C receptors, the affinities of the isomers of MDMA and MDA were at least 2-3 orders of magnitude less than 5-HT. Despite the weak effect of these compounds at the 5-HT2A and 5-HT2C receptors, these substituted amphetamines do possess intrinsic activity which may contribute to their neurotoxic effects when administered at high doses. FAU - Nash, J F AU - Nash JF AD - Department of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-5000. FAU - Roth, B L AU - Roth BL FAU - Brodkin, J D AU - Brodkin JD FAU - Nichols, D E AU - Nichols DE FAU - Gudelsky, G A AU - Gudelsky GA LA - eng GR - DA 07427/DA/NIDA NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (Phosphatidylinositols) RN - 0 (Receptor, Serotonin, 5-HT2A) RN - 0 (Receptor, Serotonin, 5-HT2C) RN - 0 (Receptors, Serotonin) RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - 3,4-Methylenedioxyamphetamine/*pharmacology MH - 3T3 Cells/drug effects/metabolism MH - Animals MH - Cells, Cultured MH - Fibroblasts/drug effects/metabolism MH - Hydrolysis/drug effects MH - Mice MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Phosphatidylinositols/*metabolism MH - Receptor, Serotonin, 5-HT2A MH - Receptor, Serotonin, 5-HT2C MH - Receptors, Serotonin/*drug effects/physiology MH - Stereoisomerism MH - Structure-Activity Relationship EDAT- 1994/08/15 00:00 MHDA- 1994/08/15 00:01 CRDT- 1994/08/15 00:00 PHST- 1994/08/15 00:00 [pubmed] PHST- 1994/08/15 00:01 [medline] PHST- 1994/08/15 00:00 [entrez] AID - 0304-3940(94)90057-4 [pii] AID - 10.1016/0304-3940(94)90057-4 [doi] PST - ppublish SO - Neurosci Lett. 1994 Aug 15;177(1-2):111-5. doi: 10.1016/0304-3940(94)90057-4.